| Literature DB >> 27047044 |
Kruti Debnath Mandal1, M R Das1, M Pati1, P D Pati2, A R Gupta1, R C Patra1, S K Senapati1.
Abstract
AIM: The present study was undertaken to evaluate the ameliorative potential of dried Moringa oleifera fruit powder in fluorosis affected calves reared around the vicinity of aluminium smelter plant.Entities:
Keywords: Moringa oleifera; aluminum smelter; boron; calcium; calves; fluorosis
Year: 2015 PMID: 27047044 PMCID: PMC4774752 DOI: 10.14202/vetworld.2015.1364-1369
Source DB: PubMed Journal: Vet World ISSN: 0972-8988
Plasma fluoride and hematological parameters in different groups of calves.
| Group (n=10) | Day 0 | Day 30 | Day 60 |
|---|---|---|---|
| Plasma fluoride concentration (ppm) | |||
| I | 0.084±0.004A | 0.086±0.007A | 0.087±0.011A |
| II | 0.523±0.009B | 0.537±0.009C | 0.542±0.012C |
| III | 0.531±0.025cB | 0.277±0.027bB | 0.221±0.027aB |
| IV | 0.549±0.029cB | 0.295±0.020bB | 0.215±0.019aB |
| Hb (g/dL) | |||
| I | 10.933±0.341B | 11.100±0.333B | 11.100±0.276C |
| II | 7.566±0.370A | 7.270±0.400A | 7.368±0.371A |
| III | 7.333±0.312A | 7.516±0.258A | 8.695±0.386Bb |
| IV | 7.333±0.363A | 7.866±0.256A | 8.246±0.310AB |
| PCV (%) | |||
| I | 32.833±1.108B | 33.000±1.154B | 33.500±0.991B |
| II | 22.666±1.256A | 23.333±1.308A | 22. 833±1.137A |
| III | 22.833±1.470A | 23.333±1.382A | 27.166±1.740A |
| IV | 22.666±1.584A | 24.000±1.527A | 25.000±1.211A |
| TLC (103per cu mm of blood) | |||
| I | 8933.333±294.863B | 8475.00±243.84B | 8483.333±209.629C |
| II | 5575.000±224.629A | 5375.000±106.262A | 5933.000±392.994A |
| III | 5533.333±463.621aA | 5700.000±157.056aA | 7550.000±232.02bB |
| IV | 5483.333±149.257aA | 5783.333±177.795aA | 6850.000±172.723bB |
Group I: Healthy control; Group II: Disease control; Group III: Moringa treatment; Group IV: Ca+B treatment. Values (mean±SE) having no common superscript (small letter in a row and capital letter in a column) differ significantly at p<0.05. SE=Standard error, Ca+B=Calcium+boron, TLC=Total leukocyte count, Hb=Hemoglobin, PCV=Packed cell volume
Differential leukocyte counts in different groups of calves.
| Group (n=10) | Day 0 | Day 30 | Day 60 |
|---|---|---|---|
| Lymphocyte count (%) | |||
| I | 57.833±0.401A | 58.166±0.749A | 58.166±0.401A |
| II | 66.500±1.118B | 66.330±1.145B | 66.166±1.376C |
| III | 67.670±1.837bB | 63.670±0.76aB | 62.340±0.557aB |
| IV | 68.170±1.351bB | 64.170±0.909aB | 61.840±0.401aB |
| Neutrophil count (%) | |||
| I | 38.833±0.166B | 37.500±0.718C | 37.166±0.477C |
| II | 22.830±1.013A | 23.833±0.833A | 22.000±1.549A |
| III | 23.666±0.421aA | 26.833±0.792bB | 31.340±0.802cB |
| IV | 23.000±0.447aA | 26.833±1.137bB | 31.170±0.477cB |
| Eosinophils count (%) | |||
| I | 2.161±0.307A | 3.000±0.258A | 2.167±0.360A |
| II | 9.833±0.703B | 8.833±0.477B | 9.666±0.421C |
| III | 9.333±0.614bB | 7.833±0.401bB | 4.833±0.542aB |
| IV | 8.5±1.087bB | 7.833±0.307bB | 4.500±0.342aB |
Group I: Healthy control; Group II: Disease control; Group III: Moringa treatment; Group IV: Ca+B treatment. Values (mean±SE) having no common superscript (small letter in a row and capital letter in a column) differ significantly at p<0.05. SE=Standard error, Ca+B=Calcium+boron
Different erythrocyte indices in different groups of calves.
| Group (n=10) | Day 0 | Day 30 | Day 60 |
|---|---|---|---|
| TEC (106 per cu mm of blood) | |||
| I | 7.530±0.349B | 7.553±0.408B | 7.673±0.481C |
| II | 4.811±0.275A | 5.053±0.285A | 4.843±0.198A |
| III | 4.818±0.218Aa | 5.335±0.244Aab | 5.791±0.280Bb |
| IV | 4.920±0.133A | 5.351±0.205A | 5.600±0.251AB |
| MCV (fL) | |||
| I | 43.933±1.998 | 44.092±2.013 | 44.318±2.389 |
| II | 47.406±2.382 | 46.321±1.811 | 47.180±1.669 |
| III | 47.559±3.152 | 43.606±0.834 | 47.011±2.673 |
| IV | 46.128±3.075 | 44.799±2.137 | 44.629±0.679 |
| MCH (pg/dL) | |||
| I | 14.665±0.764 | 14.888±0.832 | 14.684±0.749 |
| II | 15.772±0.283 | 14.450±0.622 | 15.219±0.483 |
| III | 15.332±0.842 | 14.138±0.287 | 15.085±0.647 |
| IV | 14.918±0.663 | 14.741±0.405 | 14.796±0.508 |
| MCHC (g/dL) | |||
| I | 33.341±0.565 | 33.702±0.675 | 33.163±0.349 |
| II | 33.546±1.173 | 31.236±0.878 | 32.358±1.020 |
| III | 32.470±1.282 | 32.504±1.063 | 32.360±1.347 |
| IV | 32.648±0.993 | 33.162±1.260 | 33.166±1.105 |
Group I: Healthy control; Group II: Disease control; Group III: Moringa treatment; Group IV: Ca+B treatment. Values (mean±SE) having no common superscript (small letter in a row and capital letter in a column) differ significantly at p<0.05. SE=Standard error, Ca+B=Calcium+boron, TEC=Total erythrocyte count, MCV=Mean corpuscular volume, MCH=Mean corpuscular hemoglobin, MCHC=Mean corpuscular hemoglobin concentration